Loading...
Primaquine — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Primaquine
2025-Q4
Comprehensive analysis of India’s primaquine export trade — suppliers, buyers, prices, routes, and every shipment record.
39
Shipments
$687K
Trade Value
21
Suppliers
18
Buyers
19
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/primaquine
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s primaquine trade — 2025-Q4
KEY TAKEAWAY
Primaquine 2025-Q4 exports total $687.1K across 19 countries, with MACLEODS PHARMACEUTICALS LTD commanding 54.0% market share.
TOTAL SHIPMENTS
39
2025-Q4
EXPORT VALUE
$687.1K
FOB USD
TOTAL QUANTITY
11.1M
units shipped
INDIAN SUPPLIERS
21
unique exporters
GLOBAL BUYERS
18
unique importers
DESTINATIONS
19
countries
MEDIAN UNIT PRICE
$0.163
per unit
TOP-5 SHARE
97.8%
of total USD
BRANDED SHARE
43.6%
17 shipments
DOSAGE FORMS
1
product types
6 KEY FINDINGS
1
MACLEODS PHARMACEUTICALS LTD is India's #1 Primaquine exporter with $370.9K (54.0% market share).→ §5, Indian Supplier Rankings
2
Primaquine reached 19 countries, with Pakistan as the top destination ($474.6K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 3814) — top 10 suppliers control 99.8% of exports.→ §5, Indian Supplier Rankings
4
88.9% of buyers (16 of 18) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (73.8%) across 1 dosage forms.→ §7, Price Benchmarks
6
19 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 MACLEODS PHARMACEUTICALS LTD leads in volume — how do 21 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian primaquine exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Primaquine report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial primaquine trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian primaquine suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Primaquine India trade report
Product scope
Primaquine
All variants merged — branded and generic formulations of primaquine
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
39
Every commercial primaquine trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $306.5K, Nov $313.9K, Dec $66.7K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$306.5K
Oct USD
6 shipments
2
$313.9K
Nov USD
+2.4% MoM
3
$66.7K
Dec USD
-78.7% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 2.4% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $306K, making it the middle month by value.
Fig 3.2 Q4 cumulative USD reached $687K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $7K rise in Nov, $247K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $306K | 6 shipments |
| Nov | $314K | 14 shipments |
| Dec | $67K | 19 shipments |
| Q4 Total | $687K | 39 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Saudi Arabia held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: MACLEODS PHARMACEUTICALS LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import primaquine from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Pakistan absorbs 69.1% of India’s 2025-Q4 primaquine trade ($474.6K). Beyond the top 10 destinations, 19 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 10 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 19 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much primaquine India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$534K
77.7% of trade
10 countries · 19 shipments
Europe
$0
0.0% of trade
1 countries · 1 shipments
Americas
$33K
4.8% of trade
2 countries · 3 shipments
Africa
$115K
16.8% of trade
4 countries · 10 shipments
Oceania
$5K
0.8% of trade
2 countries · 6 shipments
Fig 4.1 Pakistan is the #1 corridor ($475K) — 19 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian primaquine it receives (light = low, dark = high). Orange arcs radiate from India to the top 19 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Pakistan | $475K | 3 | MACLEODS PHARMACEUTICALS LTD | $295K | IPCA LABORATORIES LTD | $180K | — | — |
| 2 | Guinea | $100K | 2 | GREEN GRAPES DIAGNOSTICS | $100K | — | — | — | — |
| 3 | Saudi Arabia | $42K | 2 | MACLEODS PHARMACEUTICALS LTD | $42K | — | — | — | — |
| 4 | Colombia | $25K | 1 | MACLEODS PHARMACEUTICALS LTD | $25K | — | — | — | — |
| 5 | Somalia | $14K | 1 | SANJEEVANI BIO-TECH EXIM PVT LTD | $14K | — | — | — | — |
| 6 | Ecuador | $7K | 2 | MACLEODS PHARMACEUTICALS LTD | $7K | — | — | — | — |
| 7 | Myanmar | $7K | 1 | LIVEALTH BIOPHARMA PVT LTD | $7K | — | — | — | — |
| 8 | Iran | $7K | 1 | S.D.PHARMACEUTICALS | $7K | — | — | — | — |
| 9 | Papua New Guinea | $5K | 5 | FINDLIFE PHARMACEUTICAL | $4K | ARIHANT EXPORTERS | $319 | MERIT ORGANICS LTD | $307 |
| 10 | Sudan | $1K | 5 | AFRO LIFESCIENCE | $972 | STAR ENTERPRISES | $91 | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 77.7% of USD — but Pakistan is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
69.1%
#1 country share
Pakistan alone
95.5%
Top 5 share
5 of 19 countries
100.0%
Top 15 share
Long tail of 4 countries = 0.0%
HHI 5041
Destination HHI
Highly concentrated
19
Countries served
Global pharma reach from India
10
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
21 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
MACLEODS PHARMACEUTICALS LTD ($370.9K, 54.0% share) and IPCA LABORATORIES LTD ($179.7K) together control 80.1% of India’s 2025-Q4 primaquine trade. The top 5 suppliers hold 97.8%. 21 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian primaquine suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 MACLEODS PHARMACEUTICALS LTD leads by $191K over IPCA LABORATORIES LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: ZYPHARS PHARMACEUTICS PVT is #18 by value but #7 by volume.
Fig 5.2 MACLEODS PHARMACEUTICALS LTD also leads by shipment count (10) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: ZYPHARS PHARMACEUTICS PVT moves from #7 by volume to #18 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 21 primaquine suppliers split into strategic segments
KEY TAKEAWAY
6 suppliers (25%) generate 98.8% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 MACLEODS PHARMACEUTICALS LTD and IPCA LABORATORIES LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 98.8% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | MACLEODS PHARMACEUTICALS LTD | 1 | 6 | $371K |
| 2 | GREEN GRAPES DIAGNOSTICS | 1 | 1 | $100K |
| 3 | SANJEEVANI BIO-TECH EXIM PVT LTD | 1 | 1 | $14K |
| 4 | LIVEALTH BIOPHARMA PVT LTD | 1 | 1 | $7K |
| 5 | S.D.PHARMACEUTICALS | 1 | 1 | $7K |
| 6 | FINDLIFE PHARMACEUTICAL | 1 | 1 | $4K |
| 7 | PHARMA CHOICE LLP | 1 | 1 | $1K |
| 8 | AFRO LIFESCIENCE | 1 | 1 | $972 |
| 9 | MILTON LIFECARE PVT LTD | 1 | 1 | $363 |
| 10 | ARIHANT EXPORTERS | 1 | 1 | $319 |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the primaquine manufacturing hubs
KEY TAKEAWAY
Mumbai Maharashtra and Silvassa together account for $475K of India’s 2025-Q4 primaquine trade.
Fig 5.5 Mumbai Maharashtra (1 exporters, $295K) and Silvassa (1 exporters, $180K) are India’s primaquine capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
97.8%
Top 5 share
5 of 21 suppliers
99.8%
Top 10 share
10 of 21 suppliers
98.8%
Top 25% share
6 suppliers = 99% USD
HHI 3814
Supplier HHI
Concentrated
21
Total suppliers
shipped Primaquine in 2025-Q4
19+ cities
Indian hubs
Mumbai Maharashtra and Silvassa lead
§5.2 Coming next: 1 exporter deep-dive profiles
Each of the top 1 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | MACLEODS PHARMACEUTICALS LTD | $371K |
#1
EXPORTER PROFILE #1 OF 1
MACLEODS PHARMACEUTICALS LTD
Mumbai Maharashtra · India’s #1 primaquine supplier by USD · 2025-Q4
2025-Q4 USD
$371K
54.0% market share
SHIPMENTS
10
avg $37K/ship
COUNTRIES
6
destination markets
BUYERS
6
5 single-sourced
BRANDED
50%
of shipments
DOSAGE FORMS
1
product types
TOP 6 DESTINATIONS
Pakistan is the #1 market at $295K (80% of trade), followed by Saudi Arabia at $42K. 6 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Pakistan | $295K | 2 | 79.5% |
| 2 | Saudi Arabia | $42K | 2 | 11.4% |
| 3 | Colombia | $25K | 1 | 6.8% |
| 4 | Ecuador | $7K | 2 | 2.0% |
| 5 | Jordan | $726 | 2 | 0.2% |
| 6 | Yemen | $99 | 1 | 0.0% |
MONTHLY TREND
Oct peaked at $295K. Nov was the weakest at $33K.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 5/5 LOCKED IN
5 of 5 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| DIRECTORATE OF MALARIA… | Pakistan | $295K | ⚠ Locked |
| SAUDI NATIONAL BANK (S… | Saudi Arabia | $42K | ⚠ Locked |
| MINISTERIO DE SA | Colombia | $33K | ⚠ Locked |
| WHO JORDAN | Jordan | $363 | ⚠ Locked |
| Undisclosed buyer | Jordan | $363 | N/A |
| MINISTRY OF PUBLIC HEA… | Yemen | $99 | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 1 — TRADE FLOW MAP
MACLEODS PHARMACEUTICALS LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P1.3 Pakistan absorbs $295K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
18 importers across 19 countries — who is buying Indian primaquine and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 16 importers together hold only 88.8% of total USD. 89% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian primaquine. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 DIRECTORATE OF MALARIA CONTROLE BLO is the #1 importer at $295K (42.9%) — top 16 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 16 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
89%
Single-source
16 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
6%
Multi-source (3–4)
1 buyers diversified across 3–4
6%
Broad-source (5+)
1 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source primaquine from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Pakistan 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| DIRECTORATE OF MALARIA… | MACLEODS PHARMACEUTI… | $295K | $0.050 | Tablet |
| DIRECTORATE OF MALARIA… | IPCA LABORATORIES LTD | $180K | $0.045 | — |
United Arab Emirates 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MEDIMART DRUG STORE | DROPS PHARMA PVT LTD | $89.126 | $6.856 | Tablet |
| TO THE CONSIGNEE | ZYPHARS PHARMACEUTIC… | $45.282 | $4.528 | Tablet |
Guinea 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MCD GLOBAL HEALTH MINI… | GREEN GRAPES DIAGNOS… | $50K | $166.233 | Tablet |
Saudi Arabia 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| SAUDI NATIONAL BANK (S… | MACLEODS PHARMACEUTI… | $42K | $0.139 | Tablet |
Colombia 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MINISTERIO DE SA | MACLEODS PHARMACEUTI… | $33K | $0.073 | Tablet |
§6.3 Price positioning — top 16 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | DIRECTORATE OF MALAR… | Pakistan | $295K | $147K | Premium |
| 2 | DIRECTORATE OF MALAR… | Pakistan | $180K | $180K | Premium |
| 3 | MCD GLOBAL HEALTH MI… | Guinea | $50K | $50K | Premium |
| 4 | SAUDI NATIONAL BANK … | Saudi Arabia | $42K | $21K | Mid |
| 5 | MINISTERIO DE SA | Colombia | $33K | $11K | Budget |
| 6 | MAH DAROUY HAKIM | Iran | $7K | $7K | Budget |
| 7 | IMPORT INNOVATORS VE… | Philippines | $1K | $1K | Budget |
| 8 | MADAU KUAAC AYAI KON | Sudan | $727.785 | $243.000 | Budget |
| 9 | WHO JORDAN | Jordan | $362.984 | $363.000 | Budget |
| 10 | GULF PHARMACIES W.L.L | Bahrain | $362.862 | $363.000 | Budget |
| 11 | SESAGO HEALTHCARE LTD | Papua New Guinea | $319.417 | $319.000 | Budget |
| 12 | AS PER INVOICE KENYA | Kenya | $167.039 | $84.000 | Budget |
| 13 | MINISTRY OF PUBLIC H… | Yemen | $98.946 | $99.000 | Budget |
| 14 | MEDIMART DRUG STORE | United Arab Emirates | $89.126 | $89.000 | Budget |
| 15 | TO THE CONSIGNEE | United Arab Emirates | $45.282 | $23.000 | Budget |
| 16 | TO THE, IMPORTING DE… | Italy | $0.399 | $0.0000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 16 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 MACLEODS PHARMACEUTICALS LTD → DIRECTORATE OF MALARIA CONTROLE BLO is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 16 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian primaquine prices vary by supplier, country and dosage form
KEY TAKEAWAY
Primaquine prices span 210004× ($0.0008 → $166.23). The coefficient of variation is 3.39. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0008 | Lowest observed unit price |
| P5 | $0.020 | 5th percentile |
| P25 | $0.072 | 25th percentile (Q1) |
| Median | $0.163 | 50th percentile (Q2) |
| P75 | $4.53 | 75th percentile (Q3) |
| P95 | $24.78 | 95th percentile |
| Max | $166.23 | Highest observed unit price |
| Mean | $10.71 | Arithmetic average |
| CV | 339% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 GREEN GRAPES DIAGNOSTICS prices at $166.23/unit vs market median $0.163.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. MACLEODS PHARMACEUTICALS LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. GREEN GRAPES DIAGNOSTICS Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | GREEN GRAPES DIA… | Guinea | Tablet | 300 | $50K | $166.23 | Specialty / small-batch |
| Nov 2025 | GREEN GRAPES DIA… | Guinea | Tablet | 300 | $50K | $166.23 | Specialty / small-batch |
| Nov 2025 | STAR ENTERPRISES | Sudan | Tablet | 10 | $90.59 | $9.06 | Specialty / small-batch |
| Dec 2025 | MCARE IMPEX PVT … | Malaysia | Tablet | 1 | $9.03 | $9.03 | Specialty / small-batch |
| Dec 2025 | MCARE IMPEX PVT … | Malaysia | Tablet | 1 | $9.03 | $9.03 | Specialty / small-batch |
| Dec 2025 | MILTON LIFECARE … | Bahrain | Tablet | 43 | $362.86 | $8.44 | Specialty / small-batch |
| Dec 2025 | VAMA LIFECARE PV… | Kenya | Tablet | 10 | $83.52 | $8.35 | Specialty / small-batch |
| Dec 2025 | VAMA LIFECARE PV… | Kenya | Tablet | 10 | $83.52 | $8.35 | Specialty / small-batch |
| Oct 2025 | DROPS PHARMA PVT… | United Arab Emirates | Tablet | 13 | $89.13 | $6.86 | Specialty / small-batch |
| Dec 2025 | ZYPHARS PHARMACE… | United Arab Emirates | Tablet | 5 | $23.39 | $4.68 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | MERIT ORGANICS LTD | Papua New Guinea | Tablet | 20K | $306.98 | $0.015 | |
| Nov 2025 | BIOLOG PHARMA PV… | Papua New Guinea | Tablet | 330 | $6.60 | $0.020 | Small sample / trial shipment |
| Dec 2025 | S.D.PHARMACEUTIC… | Iran | Tablet | 300K | $7K | $0.024 | |
| Nov 2025 | IPCA LABORATORIE… | Pakistan | — | 4.0M | $180K | $0.045 | Bulk volume discount |
| Dec 2025 | ZIL PHARMA | United Arab Emirates | Tablet | 3K | $151.45 | $0.049 | |
| Dec 2025 | ZIL PHARMA | United Arab Emirates | Tablet | 200 | $9.77 | $0.049 | Small sample / trial shipment |
| Oct 2025 | MACLEODS PHARMAC… | Pakistan | Tablet | 464K | $23K | $0.050 | |
| Oct 2025 | MACLEODS PHARMAC… | Pakistan | Tablet | 5.4M | $272K | $0.050 | Bulk volume discount |
| Nov 2025 | MACLEODS PHARMAC… | Ecuador | Tablet | 49K | $4K | $0.072 | |
| Nov 2025 | MACLEODS PHARMAC… | Colombia | Tablet | 349K | $25K | $0.072 |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship primaquine, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Primaquine leaves India through 6+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), MUMBAI AIR (SAHAR), DELHI AIR) handle 100.0% of total USD. AIR moves 82% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $306K — top 6 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Islamabad is the #1 global destination port — top 22 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 82% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$366K
53.3% of USD · 82.1% of ships
SEA
$306K
44.6% of USD · 15.4% of ships
ICD
$14K
2.1% of USD · 2.6% of ships
Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → Asia ($302K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Ecuador is the most concentrated destination (HHI 10000, 1 suppliers). United Arab Emirates is the most competitive (HHI 4118).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Ecuador (HHI 10,000) is the most concentrated — United Arab Emirates (HHI 4,118) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 19 of 19 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| DIRECTORATE OF MALAR… | Pakistan | MACLEODS PHARMAC… | $295K | 2 | HIGH |
| DIRECTORATE OF MALAR… | Pakistan | IPCA LABORATORIE… | $180K | 1 | HIGH |
| MCD GLOBAL HEALTH MI… | Guinea | GREEN GRAPES DIA… | $50K | 1 | MEDIUM |
| SAUDI NATIONAL BANK … | Saudi Arabia | MACLEODS PHARMAC… | $42K | 2 | MEDIUM |
| MINISTERIO DE SA | Colombia | MACLEODS PHARMAC… | $33K | 3 | MEDIUM |
| MAH DAROUY HAKIM | Iran | S.D.PHARMACEUTIC… | $7K | 1 | MEDIUM |
| IMPORT INNOVATORS VE… | Philippines | PHARMA CHOICE LLP | $1K | 1 | MEDIUM |
| MADAU KUAAC AYAI KON | Sudan | AFRO LIFESCIENCE | $728 | 3 | MEDIUM |
Conclusion: 16 buyers depend on exactly one Indian supplier, representing $610K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Pakistan | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Guinea | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Saudi Arabia | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Colombia | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Somalia | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Ecuador | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Myanmar | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Iran | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Papua New Guinea | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Sudan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Philippines | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Jordan | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Bahrain | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Solomon Islands | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Pakistan | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Ecuador lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Pakistan (2 suppliers) | This Q | HIGH |
| A6 | Enter Guinea (1 suppliers) | This Q | MED |
| A8 | Build Guinea distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Pakistan tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Pakistan | Asia | 2 | $475K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Guinea | Africa | 1 | $100K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Saudi Arabia | Other | 1 | $42K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Colombia | Other | 1 | $25K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Somalia | Africa | 1 | $14K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Ecuador | Other | 1 | $7K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Myanmar | Asia | 1 | $7K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Iran | Other | 1 | $7K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Papua New Guinea | Other | 4 | $5K | -85.4% | LOW | Low competition (4 suppliers), accessible market |
| 10 | Sudan | Africa | 2 | $1K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Philippines | Asia | 1 | $1K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Jordan | Other | 1 | $726 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | United Arab Emirates | Other | 3 | $296 | +131.7% | LOW | Growing 132% with only 3 competitors |
| 14 | Bahrain | Other | 1 | $363 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Solomon Islands | Other | 1 | $318 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 39 2025-Q4 Primaquine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/primaquine
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 39 2025-Q4 primaquine shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian primaquine shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
39
across all regions
TOTAL USD
$687K
2025-Q4 FOB value
UNITS
11.1M
tablets, capsules, etc.
SUPPLIERS
21
Indian exporters
BUYERS
18
global importers
COUNTRIES
19
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $115K (16.8%), spanning 4 countries.
21 Indian suppliers shipped to 18 buyers across 19 countries — average shipment value $18K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
4 countries · 10 shipments · $115K · 5 Indian suppliers · 5 buyers
SHIPMENTS
10
USD
$115K
COUNTRIES
4
SUPPLIERS
5
BUYERS
5
HHI
7,642
concentrated
Top 4 destination countries in Africa
1
Guinea (86.5%)
$100K
2
Somalia (12.4%)
$14K
3
Sudan (0.9%)
$1K
4
Kenya (0.1%)
$167.04
Top 5 Indian suppliers into Africa
1
GREEN GRAPES DIAGNOSTICS
$100K
2
SANJEEVANI BIO-TECH EXIM PVT LTD
$14K
3
AFRO LIFESCIENCE
$971.68
4
VAMA LIFECARE PVT LTD
$167.04
5
STAR ENTERPRISES
$90.59
Top 3 Africa importers
1
MCD GLOBAL HEALTH MINISTERIO DE · Guinea
$50K
2
MADAU KUAAC AYAI KON · Sudan
$727.78
3
AS PER INVOICE KENYA · Kenya
$167.04
Top 1 dosage forms
1
Tablet
$115K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 7 | $101K | $14K |
| Dec | 3 | $14K | $5K |
Shipment register · 10 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — GREEN GRAPES DIAGNOSTICS · 2 shipments · $100K | |||||||||||
| 1 | Nov 2025 | MCD GLOBAL HEALTH MINISTERIO DE | Guinea | Tablet | 300 | NOS | $166.23 | $50K | DELHI AIR | MALABO | AIR |
| 2 | Nov 2025 | UNKNOWN BUYER | Guinea | Tablet | 300 | NOS | $166.23 | $50K | DELHI AIR | MALABO | AIR |
| SUPPLIER #2 — SANJEEVANI BIO-TECH EXIM PVT LTD · 1 shipments · $14K | |||||||||||
| 3 | Dec 2025 | UNLISTED BUYER | Somalia | Tablet | 6.0K | NOS | $2.38 | $14K | AHMEDABAD ICD | BERBERA | ICD |
| SUPPLIER #3 — AFRO LIFESCIENCE · 4 shipments · $971.68 | |||||||||||
| 4 | Nov 2025 | MADAU KUAAC AYAI KON | Sudan | Tablet | 1.5K | PCS | $0.160 | $239.99 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| 5 | Nov 2025 | MADAU KUAAC AYAI KON | Sudan | Tablet | 1.5K | PCS | $0.163 | $243.90 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| 6 | Nov 2025 | UNKNOWN BUYER | Sudan | Tablet | 1.5K | PCS | $0.163 | $243.90 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| 7 | Nov 2025 | MADAU KUAAC AYAI KON | Sudan | Tablet | 1.5K | PCS | $0.163 | $243.90 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| SUPPLIER #4 — VAMA LIFECARE PVT LTD · 2 shipments · $167.04 | |||||||||||
| 8 | Dec 2025 | AS PER INVOICE KENYA | Kenya | Tablet | 10 | NOS | $8.35 | $83.52 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 9 | Dec 2025 | AS PER INVOICE KENYA | Kenya | Tablet | 10 | NOS | $8.35 | $83.52 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #5 — STAR ENTERPRISES · 1 shipments · $90.59 | |||||||||||
| 10 | Nov 2025 | UNLISTED BUYER | Sudan | Tablet | 10 | NOS | $9.06 | $90.59 | MUMBAI AIR (SAHAR) | JUBA | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
10 countries · 19 shipments · $534K · 10 Indian suppliers · 12 buyers
SHIPMENTS
19
USD
$534K
COUNTRIES
10
SUPPLIERS
10
BUYERS
12
HHI
5,147
concentrated
Top 10 destination countries in Asia
1
Pakistan (88.9%)
$475K
2
Saudi Arabia (8.0%)
$42K
3
Myanmar (1.4%)
$7K
4
Iran (1.3%)
$7K
5
Philippines (0.2%)
$1K
6
Jordan (0.1%)
$725.97
7
Bahrain (0.1%)
$362.86
8
United Arab Emirates (0.1%)
$295.62
9
Yemen (0.0%)
$98.95
10
Malaysia (0.0%)
$18.06
Top 10 Indian suppliers into Asia
1
MACLEODS PHARMACEUTICALS LTD
$338K
2
IPCA LABORATORIES LTD
$180K
3
LIVEALTH BIOPHARMA PVT LTD
$7K
4
S.D.PHARMACEUTICALS
$7K
5
PHARMA CHOICE LLP
$1K
6
MILTON LIFECARE PVT LTD
$362.86
7
ZIL PHARMA
$161.22
8
DROPS PHARMA PVT LTD
$89.13
9
ZYPHARS PHARMACEUTICS PVT LTD
$45.28
10
MCARE IMPEX PVT LTD
$18.06
Top 10 Asia importers
1
DIRECTORATE OF MALARIA CONTROLE BLO · Pakistan
$295K
2
DIRECTORATE OF MALARIA CONTROL · Pakistan
$180K
3
SAUDI NATIONAL BANK (SNB) · Saudi Arabia
$42K
4
MAH DAROUY HAKIM · Iran
$7K
5
IMPORT INNOVATORS VENTURES INC · Philippines
$1K
6
WHO JORDAN · Jordan
$362.98
7
GULF PHARMACIES W.L.L · Bahrain
$362.86
8
MINISTRY OF PUBLIC HEALTH AND POPUL · Yemen
$98.95
9
MEDIMART DRUG STORE · United Arab Emirates
$89.13
10
TO THE CONSIGNEE · United Arab Emirates
$45.28
Top 2 dosage forms
1
Tablet
$354K
2
Unknown
$180K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 4 | $302K | $76K |
| Nov | 3 | $180K | $60K |
| Dec | 12 | $51K | $4K |
Shipment register · 19 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MACLEODS PHARMACEUTICALS LTD · 7 shipments · $338K | |||||||||||
| 1 | Oct 2025 | DIRECTORATE OF MALARIA CONTROLE BLO | Pakistan | Tablet | 464.4K | NOS | $0.050 | $23K | NHAVA SHEVA SEA (JNPT) | Islamabad | SEA |
| 2 | Oct 2025 | DIRECTORATE OF MALARIA CONTROLE BLO | Pakistan | Tablet | 5.4M | NOS | $0.050 | $272K | NHAVA SHEVA SEA (JNPT) | Islamabad | SEA |
| 3 | Nov 2025 | WHO JORDAN | Jordan | Tablet | 5.0K | NOS | $0.073 | $362.98 | DELHI AIR | AMMAN | AIR |
| 4 | Nov 2025 | UNKNOWN BUYER | Jordan | Tablet | 5.0K | NOS | $0.073 | $362.98 | DELHI AIR | AMMAN | AIR |
| 5 | Dec 2025 | SAUDI NATIONAL BANK (SNB) | Saudi Arabia | Tablet | 100.0K | NOS | $0.111 | $11K | MUMBAI AIR (SAHAR) | RIYADH | AIR |
| 6 | Dec 2025 | SAUDI NATIONAL BANK (SNB) | Saudi Arabia | Tablet | 205.3K | NOS | $0.153 | $31K | MUMBAI AIR (SAHAR) | RIYADH | AIR |
| 7 | Dec 2025 | MINISTRY OF PUBLIC HEALTH AND POPUL | Yemen | Tablet | 125.0K | NOS | $0.0008 | $98.95 | NHAVA SHEVA SEA (JNPT) | Aden | SEA |
| SUPPLIER #2 — IPCA LABORATORIES LTD · 1 shipments · $180K | |||||||||||
| 8 | Nov 2025 | DIRECTORATE OF MALARIA CONTROL | Pakistan | 4.0M | NOS | $0.045 | $180K | MUMBAI AIR (SAHAR) | ISLAMABAD - ISLAMABA | AIR | |
| SUPPLIER #3 — LIVEALTH BIOPHARMA PVT LTD · 1 shipments · $7K | |||||||||||
| 9 | Oct 2025 | UNLISTED BUYER | Myanmar | Tablet | 6.0K | NOS | $1.20 | $7K | NHAVA SHEVA SEA (JNPT) | Yangon | SEA |
| SUPPLIER #4 — S.D.PHARMACEUTICALS · 1 shipments · $7K | |||||||||||
| 10 | Dec 2025 | MAH DAROUY HAKIM | Iran | Tablet | 299.6K | NOS | $0.024 | $7K | DELHI AIR | TEHRAN | AIR |
| SUPPLIER #5 — PHARMA CHOICE LLP · 1 shipments · $1K | |||||||||||
| 11 | Dec 2025 | IMPORT INNOVATORS VENTURES INC | Philippines | Tablet | 500 | NOS | $2.03 | $1K | MUMBAI AIR (SAHAR) | CLARK INTER. AIRPORT | AIR |
| SUPPLIER #6 — MILTON LIFECARE PVT LTD · 1 shipments · $362.86 | |||||||||||
| 12 | Dec 2025 | GULF PHARMACIES W.L.L | Bahrain | Tablet | 43 | NOS | $8.44 | $362.86 | MUMBAI AIR (SAHAR) | BAHRAIN | AIR |
| SUPPLIER #7 — ZIL PHARMA · 2 shipments · $161.22 | |||||||||||
| 13 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 200 | NOS | $0.049 | $9.77 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 14 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 3.1K | NOS | $0.049 | $151.45 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #8 — DROPS PHARMA PVT LTD · 1 shipments · $89.13 | |||||||||||
| 15 | Oct 2025 | MEDIMART DRUG STORE | United Arab Emirates | Tablet | 13 | NOS | $6.86 | $89.13 | COCHIN SEA | DUBAI | AIR |
| SUPPLIER #9 — ZYPHARS PHARMACEUTICS PVT LTD · 2 shipments · $45.28 | |||||||||||
| 16 | Dec 2025 | TO THE CONSIGNEE | United Arab Emirates | Tablet | 5 | NOS | $4.68 | $23.39 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 17 | Dec 2025 | TO THE CONSIGNEE | United Arab Emirates | Tablet | 5 | NOS | $4.38 | $21.89 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #10 — MCARE IMPEX PVT LTD · 2 shipments · $18.06 | |||||||||||
| 18 | Dec 2025 | UNLISTED BUYER | Malaysia | Tablet | 1 | PCS | $9.03 | $9.03 | DELHI AIR | KUALA LUMPUR - INT'L | AIR |
| 19 | Dec 2025 | UNLISTED BUYER | Malaysia | Tablet | 1 | PCS | $9.03 | $9.03 | DELHI AIR | KUALA LUMPUR - INT'L | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
1 countries · 1 shipments · $0.399 · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$0.399
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Europe
1
Italy (100.0%)
$0.399
Top 1 Indian suppliers into Europe
1
JPC GLOBAL
$0.399
Top 1 Europe importers
1
TO THE, IMPORTING DEPARTMENT · Italy
$0.399
Top 1 dosage forms
1
Tablet
$0.399
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 1 | $0.399 | $0.399 |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — JPC GLOBAL · 1 shipments · $0.399 | |||||||||||
| 1 | Dec 2025 | TO THE, IMPORTING DEPARTMENT | Italy | Tablet | 5 | PCS | $0.080 | $0.399 | MUMBAI AIR (SAHAR) | MILAN | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
2 countries · 3 shipments · $33K · 1 Indian suppliers · 1 buyers
SHIPMENTS
3
USD
$33K
COUNTRIES
2
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 2 destination countries in Americas
1
Colombia (77.1%)
$25K
2
Ecuador (22.9%)
$7K
Top 1 Indian suppliers into Americas
1
MACLEODS PHARMACEUTICALS LTD
$33K
Top 1 Americas importers
1
MINISTERIO DE SA · Colombia
$33K
Top 1 dosage forms
1
Tablet
$33K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 3 | $33K | $11K |
| Dec | 0 | $0.0000 | — |
Shipment register · 3 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MACLEODS PHARMACEUTICALS LTD · 3 shipments · $33K | |||||||||||
| 1 | Nov 2025 | MINISTERIO DE SA | Colombia | Tablet | 348.6K | NOS | $0.072 | $25K | DELHI AIR | BOGOTA | AIR |
| 2 | Nov 2025 | MINISTERIO DE SA | Ecuador | Tablet | 49.0K | NOS | $0.081 | $4K | DELHI AIR | QUITO | AIR |
| 3 | Nov 2025 | MINISTERIO DE SA | Ecuador | Tablet | 49.0K | NOS | $0.072 | $4K | DELHI AIR | QUITO | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
2 countries · 6 shipments · $5K · 5 Indian suppliers · 2 buyers
SHIPMENTS
6
USD
$5K
COUNTRIES
2
SUPPLIERS
5
BUYERS
2
HHI
6,811
concentrated
Top 2 destination countries in Oceania
1
Papua New Guinea (93.9%)
$5K
2
Solomon Islands (6.1%)
$317.75
Top 5 Indian suppliers into Oceania
1
FINDLIFE PHARMACEUTICAL
$4K
2
ARIHANT EXPORTERS
$319.42
3
NEVISUN PHARMACEUTICAL PVT LTD
$317.75
4
MERIT ORGANICS LTD
$306.98
5
BIOLOG PHARMA PVT LTD
$6.60
Top 1 Oceania importers
1
SESAGO HEALTHCARE LTD · Papua New Guinea
$319.42
Top 1 dosage forms
1
Tablet
$5K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $4K | $2K |
| Nov | 1 | $6.60 | $6.60 |
| Dec | 3 | $944.15 | $314.72 |
Shipment register · 6 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — FINDLIFE PHARMACEUTICAL · 2 shipments · $4K | |||||||||||
| 1 | Oct 2025 | UNLISTED BUYER | Papua New Guinea | Tablet | 2.9K | NOS | $1.20 | $3K | NHAVA SHEVA SEA (JNPT) | Lae | SEA |
| 2 | Oct 2025 | UNLISTED BUYER | Papua New Guinea | Tablet | 366 | NOS | $2.19 | $800.11 | NHAVA SHEVA SEA (JNPT) | Lae | SEA |
| SUPPLIER #2 — ARIHANT EXPORTERS · 1 shipments · $319.42 | |||||||||||
| 3 | Dec 2025 | SESAGO HEALTHCARE LTD | Papua New Guinea | Tablet | 100 | PCS | $3.19 | $319.42 | MUMBAI AIR (SAHAR) | PORT MORESBY | AIR |
| SUPPLIER #3 — NEVISUN PHARMACEUTICAL PVT LTD · 1 shipments · $317.75 | |||||||||||
| 4 | Dec 2025 | UNLISTED BUYER | Solomon Islands | Tablet | 100 | NOS | $3.18 | $317.75 | MUMBAI AIR (SAHAR) | HONIARA | AIR |
| SUPPLIER #4 — MERIT ORGANICS LTD · 1 shipments · $306.98 | |||||||||||
| 5 | Dec 2025 | UNLISTED BUYER | Papua New Guinea | Tablet | 20.0K | NOS | $0.015 | $306.98 | MUMBAI AIR (SAHAR) | PORT MORESBY | AIR |
| SUPPLIER #5 — BIOLOG PHARMA PVT LTD · 1 shipments · $6.60 | |||||||||||
| 6 | Nov 2025 | UNLISTED BUYER | Papua New Guinea | Tablet | 330 | NOS | $0.020 | $6.60 | AHMEDABAD AIR | PORT MORESBY | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 21 Indian primaquine exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped primaquine in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | MACLEODS PHARMACEUTICALS LTD | MUMBAI MAHARASHTRA | 10 | $371K | Tablet | Asia, Americas |
| 2 | IPCA LABORATORIES LTD | SILVASSA | 1 | $180K | Asia | |
| 3 | GREEN GRAPES DIAGNOSTICS | NEW DELHI | 2 | $100K | Tablet | Africa |
| 4 | SANJEEVANI BIO-TECH EXIM PVT LTD | AHMEDABAD | 1 | $14K | Tablet | Africa |
| 5 | LIVEALTH BIOPHARMA PVT LTD | MUMBAI | 1 | $7K | Tablet | Asia |
| 6 | S.D.PHARMACEUTICALS | CENTER VIKAS PURI NEW DELHI | 1 | $7K | Tablet | Asia |
| 7 | FINDLIFE PHARMACEUTICAL | N/A | 2 | $4K | Tablet | Oceania |
| 8 | PHARMA CHOICE LLP | MULUND EAST | 1 | $1K | Tablet | Asia |
| 9 | AFRO LIFESCIENCE | MUMBAI | 4 | $971.68 | Tablet | Africa |
| 10 | MILTON LIFECARE PVT LTD | MUMBAI | 1 | $362.86 | Tablet | Asia |
| 11 | ARIHANT EXPORTERS | SURENDRANAGAR | 1 | $319.42 | Tablet | Oceania |
| 12 | NEVISUN PHARMACEUTICAL PVT LTD | Surat City | 1 | $317.75 | Tablet | Oceania |
| 13 | MERIT ORGANICS LTD | VALSAD | 1 | $306.98 | Tablet | Oceania |
| 14 | VAMA LIFECARE PVT LTD | MUMBAI | 2 | $167.04 | Tablet | Africa |
| 15 | ZIL PHARMA | MUMBAI | 2 | $161.22 | Tablet | Asia |
| 16 | STAR ENTERPRISES | MUMBAI | 1 | $90.59 | Tablet | Africa |
| 17 | DROPS PHARMA PVT LTD | HOSDURG | 1 | $89.13 | Tablet | Asia |
| 18 | ZYPHARS PHARMACEUTICS PVT LTD | PUNE | 2 | $45.28 | Tablet | Asia |
| 19 | MCARE IMPEX PVT LTD | ALIGARH | 2 | $18.06 | Tablet | Asia |
| 20 | BIOLOG PHARMA PVT LTD | AHMEDABAD | 1 | $6.60 | Tablet | Oceania |
| 21 | JPC GLOBAL | MUMBAI | 1 | $0.399 | Tablet | Europe |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 16 global primaquine importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian primaquine in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | DIRECTORATE OF MALARIA CONTROLE BLO | Pakistan | 2 | $295K | MACLEODS PHARMACEUTI… | Tablet |
| 2 | DIRECTORATE OF MALARIA CONTROL | Pakistan | 1 | $180K | IPCA LABORATORIES LTD | |
| 3 | MCD GLOBAL HEALTH MINISTERIO DE | Guinea | 1 | $50K | GREEN GRAPES DIAGNOS… | Tablet |
| 4 | SAUDI NATIONAL BANK (SNB) | Saudi Arabia | 2 | $42K | MACLEODS PHARMACEUTI… | Tablet |
| 5 | MINISTERIO DE SA | Colombia | 3 | $33K | MACLEODS PHARMACEUTI… | Tablet |
| 6 | MAH DAROUY HAKIM | Iran | 1 | $7K | S.D.PHARMACEUTICALS | Tablet |
| 7 | IMPORT INNOVATORS VENTURES INC | Philippines | 1 | $1K | PHARMA CHOICE LLP | Tablet |
| 8 | MADAU KUAAC AYAI KON | Sudan | 3 | $727.78 | AFRO LIFESCIENCE | Tablet |
| 9 | WHO JORDAN | Jordan | 1 | $362.98 | MACLEODS PHARMACEUTI… | Tablet |
| 10 | GULF PHARMACIES W.L.L | Bahrain | 1 | $362.86 | MILTON LIFECARE PVT … | Tablet |
| 11 | SESAGO HEALTHCARE LTD | Papua New Guinea | 1 | $319.42 | ARIHANT EXPORTERS | Tablet |
| 12 | AS PER INVOICE KENYA | Kenya | 2 | $167.04 | VAMA LIFECARE PVT LTD | Tablet |
| 13 | MINISTRY OF PUBLIC HEALTH AND POPUL | Yemen | 1 | $98.95 | MACLEODS PHARMACEUTI… | Tablet |
| 14 | MEDIMART DRUG STORE | United Arab Emirates | 1 | $89.13 | DROPS PHARMA PVT LTD | Tablet |
| 15 | TO THE CONSIGNEE | United Arab Emirates | 2 | $45.28 | ZYPHARS PHARMACEUTIC… | Tablet |
| 16 | TO THE, IMPORTING DEPARTMENT | Italy | 1 | $0.399 | JPC GLOBAL | Tablet |
This report covers 39 2025-Q4 Primaquine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/primaquine
Talk to our trade analyst
Need a custom primaquine report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/primaquine
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Primaquine product page
Live data, supplier directory, price trends, and trade route analysis